Thu Jun 20 03:05:28 SGT 2013  
    Genital Warts Treatment, Timor-Leste
HIV STD TESTING TREATMENT™

Notice: This is a medical information portal. This is not a clinic website.
Please go to SHIM CLINIC for the services described here.

Within 3 days after unprotected sex, stop HIV infection with Post-Exposure Prophylaxis treatment 10 days after unprotected sex, detect HIV infection with the DNA test 28 days after unprotected sex, accurately detect HIV infection with the 20 minute rapid test
Full & comprehensive sexually transmitted disease testing
Males: do not urinate for at least 4 hours before arriving
Females: testing is more accurate when you are not menstruating

Genital Warts Treatment, Timor-Leste | HIV STD TESTING TREATMENT™

Summary

Genital Warts Treatment, Timor-Leste | HIV STD TESTING TREATMENT™ @beautytimorleste_com: Genital warts (condyloma, condylomata acuminata, venereal wart, anal wart, anogenital wart, "cauliflower" sex disease) symptoms in men/women, screening/diagnosis, testing/check, treatment clinic, Timor-Leste - Private and confidential service. Definitions, references, and latest news.

Description

Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:

SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Genital Warts Treatment, Timor-Leste
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: half hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline Event / Available resources
HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception
(females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception
(females only)
2 weeks HIV DNA PCR test
1 month 20 minute Alere™ Determine™ Combo HIV rapid test:
- Fingerprick blood sampling.
3 months 20 minute OraQuick® HIV rapid test:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

References


Latest News

Test may predict HPV-related throat cancer
Tue, 18 Jun 2013 17:43:33 +0100 | WDSU.com - Health
Scientists may be able to predict throat cancers caused by the human papillomavirus more than 10 years before patients get diagnosed, according to research published in the Journal of Clinical Oncology. (Source: WDSU.com - Health)

Cervical screening test results associated with 265 histopathologic diagnoses of cervical glandular neoplasia.
Tue, 18 Jun 2013 07:30:03 +0100 | American Journal of Clinical Pathology
Conclusions: Conservative cytologic screening practices and HPV cotesting can facilitate early diagnoses of CGN.

Blood test one day may detect oral cancer from oral sex
Tue, 18 Jun 2013 01:52:46 +0100 | Health News - UPI.com
BETHESDA, Md., June 17 (UPI) -- A test may one day detect human papillomavirus to identify those of increased risk of HPV-related oral cancer as a result of oral sex, U.S. researchers say. (Source: Health News - UPI.com)

Oral Cancers Linked to Sex Could Be Found EarlierOral Cancers Linked to Sex Could Be Found Earlier
Mon, 17 Jun 2013 16:00:00 +0100 | Medscape Today Headlines
Antibodies to a high-risk type human papillomavirus (HPV) that causes mouth and throat cancers when transmitted via oral sex can be detected in blood tests many years before onset of the disease. Reuters Health Information (Source: Medscape Today Headlines)

Non-detection of Epstein-Barr virus and human papillomavirus in a region of high gastric cancer risk indicates a lack of a role for these viruses in gastric carcinomas
Mon, 17 Jun 2013 06:17:32 +0100 | Genetics and Molecular Biology
Gastric mucosa tissue was collected from patients with gastroduodenal diseases in a region of norrteastern China showing a high risk of gastric cancer incidence. The presence of EBV and HPV were assayed to investigate the relationship between gastric carcinomas and virus infection. Neither EBV nor HPV DNA was detected in tissue from the patients. The role of EBV and HPV in gastric cancer is not well understood and still needs to be clarified. (Source: Genetics and Molecular Biology)

NIH scientists find promising biomarker for predicting HPV-related oropharynx cancer
Mon, 17 Jun 2013 04:00:00 +0100 | EurekAlert! - Medicine and Health
(NIH/National Cancer Institute) Researchers have found that antibodies against the human papillomavirus may help identify individuals who are at greatly increased risk of HPV-related cancer of the oropharynx, which is a portion of the throat that contains the tonsils. (Source: EurekAlert! - Medicine and Health)

Circulating CD4‐positive lymphocyte levels as predictor of response to induction chemotherapy in patients with advanced laryngeal cancer
Fri, 14 Jun 2013 04:00:00 +0100 | Head and Neck
Conclusion. These findings demonstrate the potential importance of the immune system in chemotherapy response and clinical outcome. Differences in findings between patients with advanced laryngeal and oropharyngeal cancer may reflect different cellular immunity function in the patients with human papillomavirus (HPV)‐16+ oropharyngeal cancer. © 2013 Wiley Periodicals, Inc. Head Neck, 2013 (Source: Head and Neck)

Use of the HPV MLPA assay in cervical cytology for the prediction of high grade lesions
Thu, 13 Jun 2013 04:00:00 +0100 | Journal of Medical Virology
This study demonstrates that the HPV MLPA assay can reliably detect HPV 16/18, viral load, and viral integration in cytological samples. Also, high‐risk classification correlated well with the presence of high‐grade dysplasia. However, for the implementation of the MLPA assay into clinical practice, additional HR‐HPV types need to be included to increase the sensitivity of the assay, and thereby increase its negative predictive value. J. Med. Virol. 85:1386–1393, 2013. © 2013 Wiley Periodicals, Inc. (Source: Journal of Medical Virology)

Characterization of cytomegalovirus and epstein‐barr virus infection in cervical lesions in Portugal
Thu, 13 Jun 2013 04:00:00 +0100 | Journal of Medical Virology
This study revealed an overall prevalence of 4.5% for CMV and 10.1% for EBV. Age‐stratified analysis revealed that CMV infection was present in individuals <30 and >60 years old, while EBV infection was present in all age groups. CMV was detected in 9.5% of low‐grade lesions and in 22.2% of in situ/invasive carcinomas, while EBV infection was found in all different types of lesions. In addition, data revealed that CMV infection was associated with an increased risk of in situ/invasive carcinoma development (OR = 1.28; P = 0.035). The study reveals a low prevalence for both viruses; nevertheless, these results are important for knowledge on the shedding of EBV and CMV in cervical samples. J. Med. Virol. 85:1409–1413, 2013. © 2013 Wiley Periodicals, Inc. (Source: Journal...

Juvenile respiratory papillomatosis: Risk factors for severity
Thu, 13 Jun 2013 04:00:00 +0100 | Journal of Medical Virology
Abstract